UBE2Q2P8
associated omics dataQ-omics provides the consensus-scored UBE2Q2P8 profile across patient tissues and cancer cell-line models. UBE2Q2P8 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in UCEC.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for UBE2Q2P8 — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes UBE2Q2P8 survival associations across molecular data types. UBE2Q2P8 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible UBE2Q2P8 RNA expression–survival associations across cancer types. High UBE2Q2P8 expression shows unfavorable associations in UCEC and BLCA. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for UBE2Q2P8 RNA expression.
